Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O.

@article{Cavaliere2011PrognosticFA,
  title={Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O.},
  author={Francesco Cavaliere and Michele De Simone and Salvatore Virz{\`i} and Marcello Deraco and Carlo Riccardo Rossi and Alfredo Garofalo and Franco Di Filippo and Diana Giannarelli and Marco Vaira and Mario Valle and Pier Luigi Pilati and Pasquale Perri and Massimo La Pinta and Igor Monsellato and Fiorella Guadagni},
  journal={European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
  year={2011},
  volume={37 2},
  pages={148-54}
}
AIM The present study was specifically designed to assess the major clinical and pathological variables of patients with colorectal peritoneal carcinomatosis in order to investigate whether currently used criteria appropriately select candidates for peritonectomy procedures (cytoreductive surgery) combined with hyperthermic intraperitoneal chemotherapy… CONTINUE READING